Immunotherapy-Transfer Factor in Coccidioidomycosis
Since, as indicated in Chapter 5, defective immunity, notably cell-mediated immunity, is closely associated with progressive coccidioidomycosis, attempts to treat the disease by altering the host response are eminently logical. In coccidioidomycosis, almost all the clinical experience with this approach has been by the use of transfer factor. Conversely, probably no disease has provided more rationale for further clinical study of transfer factor.
KeywordsMigration Inhibition Factor Transfer Factor Related Antigen Lepromatous Leprosy Chronic Mucocutaneous Moniliasis
Unable to display preview. Download preview PDF.
- 2.H. S. Lawrence, Transfer factor, Adv. Immunol. 11:195–266 (1969).Google Scholar
- 7.E. A. Peterson, J. A. Frey, M. Dinowitz, and D. Rifkind, Transfer of delayed hypersensitivity to mice with human immune cell extracts, in: Transfer Factor—Basic Properties and Clinical Applications ( M. S. Ascher, A. A. Gottlieb, and C. H. Kirkpatrick, eds.), Academic Press, New York (1976), pp. 387–398.Google Scholar
- 16.A. Catanzaro, L. Spitler . (Coccidioidomycosis Cooperative Treatment Group), Clinical and immunologic results of transfer factor therapy in coccidioidomycosis, in: Transfer Factor—Basic Properties and Clinical Applications ( M. S. Ascher, A. A. Gottlieb, and C. H. Kirkpatrick, eds.), Academic Press, New York (1976), pp. 477–494.Google Scholar
- 17.J. R. Graybill . (Coccidioidomycosis Cooperative Treatment Group), The clinical couse of coccidioidomycosis following transfer factor therapy, in: Coccidioidomycosis: Current Clinical and Diagnostic Status ( L. Ajello, ed.), Symposia Specialists, Miami, Fla. (1977), pp. 335–345.Google Scholar
- 18.D. A. Stevens . (Coccidioidomycosis Cooperative Treatment Group), Transfer factor therapy of infectious diseases, in: Recent Advances in Dermatopharmacology ( P. Frost, E. C. Gomez, and N. Zaias, eds.), Spectrum, Holliswood, N.Y. (1977), pp. 67–74.Google Scholar